Directors Digest - Syenza

At Syenza, we understand the challenges of finding credible and reliable reviews on important themes impacting innovative healthcare technologies. That’s why we provide in-depth discussions on defined themes that shape our clients’ activities and the support we provide. All our Insight Articles are carefully researched, fully-referenced, updated frequently, and available at no cost on our website. You are welcome to use our work, but please give credit where credit is due.

How Local Clinical Trials Accelerate Drug Access and Build Health System Resilience

February 9, 2026

How Local Clinical Trials Accelerate Drug Access and Build Health System Resilience

How Local Clinical Trials Accelerate Drug Access and Build Health System Resilience For…

Ensuring Accuracy in Healthcare Valuation Verification

February 2, 2026

Ensuring Accuracy in Healthcare Valuation Verification

Ensuring Accuracy in Healthcare Valuation Verification A recent case in health economics underscores…

Composite NNT CPEA: True Value in CVD and CKM Therapies

January 26, 2026

Composite NNT CPEA: True Value in CVD and CKM Therapies

Healthcare leaders can now use composite NNT CPEA to assess treatments more fully,…

Advancing LatAm COPD Access: Chiesi Group Strategies

January 19, 2026

Advancing LatAm COPD Access: Chiesi Group Strategies

LatAm COPD access stands at the forefront of regional healthcare challenges, where vast…

NICE QALY Thresholds Rise: Impacts on NHS Access

January 12, 2026

NICE QALY Thresholds Rise: Impacts on NHS Access

NICE QALY thresholds will increase from £20,000–£30,000 to £25,000–£35,000 per quality-adjusted life year…

2026 Healthcare Strategies: Lessons from 2025

January 5, 2026

2026 Healthcare Strategies: Lessons from 2025

As we get started with 2026, let's review the top 2025 Directors Digest…